from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2596/vapC40

LFCtreatmentdescriptionclass of inhibitor

0.344

Amikacinug/mL Amikacintranslation

1.659

Cap5-10ug/mL Capreomycintranslation

4.227

Rox10-50 ug/mL Roxithromycintranslation

1.201

SM2-5 ug/mL Streptomycintranslation

0.688

Tet5-10 ug/mL Tetracyclinetranslation

-0.844

Rif0.2-5ug/mL Rifampicintranscription

-1.322

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.996

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.589

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.094

CPZ10-50 ug/mL Chlorpromazinerespiration

0.336

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.140

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.068

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.728

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.500

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.446

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.072

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.311

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.743

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.389

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.992

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.607

Nigericin50 uM Nigericinrespiration

0.015

TRC10-150 ug/mL Triclosanrespiration

-0.802

TRZ10-25 ug/mL Thioridazinerespiration

1.051

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.327

menadione6-10 ug/mL Menadionerespiration

-0.307

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.498

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.511

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.066

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.409

NRP_1Non-replicating persistence stage 1dosRassociated

0.331

Amp0.2mg/mL AmpicillincellWall

-0.198

Cephalexin20-100 ug/mL CephalexincellWall

0.069

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.564

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.338

EMB10-20 ug/mL EthambutolcellWall

-0.115

Eta12-40 ug/mL EthionamidecellWall

-0.585

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.211

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.647

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.426

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.398

BZA0.12 mg/mL BenzamidearomaticAmides

-0.286

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.251

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.031

H2O24 mM hydrogen peroxideDNAdamaging

-0.218

Levo10 ug/mL LevofloxacinDNAdamaging

0.404

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.422

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.075

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.615

UVUV-irradiationDNAdamaging

-1.299

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.842

Antimycin12.5-50 ug/mL Antimycin A?

-0.293

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.373

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.240

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.305

PA8240.2-2 ug/mL PA-824?

0.588

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.137

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.148

Verapamil50 uM Verapamil?

0.285

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.309

methoxatin10-20 ug/mL Methoxatin?